Background: 18 DNA methylation is associated with body mass index (BMI), but it is not clear if 19 methylation scores are biomarkers for extant BMI, or predictive of future BMI. 20
associations remained following adjustment for smoking exposure and 38 education levels. The DNA methylation score was found to be a poor predictor of 39 future BMI using linear and cross-lagged models, suggesting that DNA 40 methylation variation does not cause later variation in BMI. However, there was 41 some evidence to suggest that BMI is predictive of later DNA methylation. 42
Mendelian randomisation analyses also support this direction of effect, although 43 evidence is weak. Finally, we find that DNA methylation scores for BMI are 44 associated with extant cardiometabolic traits independently of BMI and genetic 45 score. 46
Conclusion: 47
The age-specific nature of DNA methylation associations with BMI, lack of causal 48 relationship, and limited predictive ability of future BMI, indicate that DNA 49
Since genetic variants are fixed at conception, genetic variants associated with 81 BMI can be used early in life to predict later BMI [16] . The relationship of DNA 82 methylation at BMI associated loci, however, is more complex. Methylation levels 83 vary over time and may change in response to environmental or phenotypic 84 changes so earlier methylation variation is not guaranteed to predict later BMI 85 levels. Recent work [14] has suggested that change in BMI is more likely to be 86 causal for changes in DNA methylation than vice versa. This would suggest that 87 current DNA methylation scores are simply biomarkers for extant BMI. However, 88 the utility of DNA methylation as a predictor for future trajectories of BMI would 89 be of considerably greater utility. 90
The first aim of our study was to investigate if there is a temporal association 91 between DNA methylation and BMI. We approached this question by using 92 genome-wide DNA methylation profiles from the Accessible Resource for 93
Integrated Epigenomics Studies (ARIES) [17] subset of the Avon Longitudinal 94
Study of Parents and Children (ALSPAC) [18, 19] . ALSPAC is a prospective cohort 95 of children born in the former county of Avon, England during 1991 and1992. 96 DNA methylation profiles were generated in children from blood collected at 97 three time points (birth, childhood, adolescence) and from their mothers at two 98 time points (during pregnancy and at middle-age). We used these DNA 99 methylation profiles along with multiple measurements of BMI genetic profiles 100 to determine if DNA methylation predicted BMI later in life, independently of 101 genetic variation and BMI itself, and vice versa. In doing so, our objective was to 102 determine if DNA methylation is a predictor for BMI or simply a biomarker that 103 proxies current or previous BMI values. 104 DNA methylation scores for BMI may be useful for the detection of adverse 105 health outcomes related to BMI. For example, Wahl et al found that DNA 106 methylation could be used to identify individuals at high risk of incident type 2 107 diabetes, independently of other explanatory factors, including BMI itself [14] . 108 Therefore, the second aim of our study was to see if DNA methylation scores for 109 BMI contributed anything above BMI itself in predicting related adverse health 110 outcomes. 111 and maternal education were used). Various answers from questions regarding 167 smoking in mothers (in pregnancy and currently) were used, from questionnaire 168 data. These included the number of cigarettes smoked per day before pregnancy, 169 during the first three months of pregnancy and the number of cigarettes smoked 170 in the last 2 weeks during or just after pregnancy. These measures were 171 combined to create a variable for whether the mother smoked in pregnancy. We 172 also used data on the number of cigarettes smoked per day, whether they 173 responded as being a current smoker and the time passed since they stopped 174 smoking if this was within the last 12 months to create a variable for current or 175 recent (within the last 12 months) smoker. Education level for the mother's was 176 also taken from questionnaire data, where participants were asked "What 177 educational qualifications do you, your partner, your mother, and your father 178 have?". They were asked to select all options that applied to them and we used 179 the highest education qualification for the participant. The options for this were 180 CSE/none, vocational, O level, A level or degree. 181
Variables for cardiovascular outcomes for middle-aged mothers and adolescents 182 were also used. These variables were from blood samples, obtained during clinic 183 visits and included fasting glucose and insulin, triglycerides and low-density 184 lipoprotein (LDL). Sitting diastolic and systolic blood pressures (SBP) from the 185 right arm were collected during clinic visits. An Omron M6 upper arm blood 186 pressure/pulse monitor was used to take 2 readings of blood pressure and then 187 mean values were used. The data for triglycerides, glucose and insulin were 188 skewed so we log transformed this data for use in analyses. repository was used and Imputation of the target data was performed with this, 217 using all reference haplotypes. A large proportion of the cohort has genome-wide 218 data from these samples and a subset of this data is used in this study [18] . 219
Genetic and epigenetic scores 220
To investigate whether reported DNA methylation associations with BMI could 221 be observed in an independent cohort, we calculated DNA methylation scores were created using Plink V1.9 (https://www.cog-genomics.org/plink2) with the 230 score and sum commands, however one of the SNPs did not meet imputation 231 score filters (rs12016871), so the score was constructed using only 96 SNPs. 232
To perform simplified versions of Mendelian randomisation (MR), we used 233 summary statistics from methylation quantitative trait loci (mQTL). mQTLs are 234 genetic variants associated with DNA methylation [24] . To identify mQTLs we 235 looked these up in mQTLdb [25] , which contains mQTLs below a conservative p-236 value threshold of 1e-07. If multiple mQTLs were identified for an individual CpG 237 site, the one with the lowest p-value reported in the GIANT study for BMI was 238 used as the mQTL for the MR analysis. If these mQTLs were unavailable, then 239 proxies of these SNPs were obtained. These were SNPs with the next lowest p-240 value for that CpG, which were also present in the BMI GWAS data. We used the 241 last p-value available in the BMI GWAS for each mQTL to maximise power. Of the 242 135 CpG sites we queried, 89 had an instrument at this threshold. 243
Statistical analysis 244
Observational associations at the same time point 245
Linear regression models, with adjustments for covariates, were used to test 246 observational associations. When testing for association between genetic and/or 247 methylation scores of BMI, BMI was the dependent variable and the methylation 248 and/or genetic score the independent variables. For models including a genetic 249 score, age was included as a covariate. For models including a methylation score, 250 the covariates included were age, sample type and estimated blood cell type 251 proportions. Sex was additionally included as a covariate in all models analysing 252 child data. For predicting BMI, BMI was used as the dependent variable, and 253 when predicting methylation, methylation score was used as the dependent 254 variable. 255
To compare the relative contributions of genetic score and methylation score to 256 BMI, an analysis of variance (ANOVA) test was carried out comparing the 257 following three models, with the full model (model 3) being compared to each of 258 the reduced models (models 1 and 2): Values for each of the free parameters or paths are estimated in the model. The 283 paths were from earlier BMI to methylation at the same time point, later 284 methylation and later BMI; and from earlier methylation to later BMI and 285 methylation; and from later BMI to methylation at the same time point. Each 286 path was sequentially tested in a sub model analysis, where that path was fixed 287 to 0 and this sub model was compared against the full model using a likelihood 288 ratio test. If a sub model had a significantly worse fit then that path was retained, 289 but otherwise dropped because it was not important to the overall system. 290
Mendelian randomisation 291
To investigate causal inference more directly, an approach based on MR was 292 adopted. To test if changes in BMI cause changes in DNA methylation, we 293 calculated genetic scores for BMI, as previously described, and tested the 294 association of this score with each of the 135 BMI-associated CpG sites. A 295
Fisher's test was then applied to combine the association p-values for all 135 296 association tests. To increase power, the adolescent and middle-aged mother's 297 data was subsequently combined, and the association was tested again using a 298 mixed model to account for relatedness. 299 Two-sample MR was applied to explore the reverse direction, i.e. a causal effect 300 of DNA methylation on BMI. In this approach, summary statistics from the BMI 301 GWAS were obtained for the mQTLs (or proxies of these, if these SNPs were 302 unavailable) for the 135 BMI-associated CpG sites. 303
Confounder analysis 304
To investigate whether any associations found between methylation and BMI 305 were due to confounding by smoking or education, we compared linear models 306 of BMI and DNA methylation with and without smoking (prenatal smoking 307 during pregnancy for children and own smoking for adults) and education as 308 covariates. 309
Cardiovascular trait analyses 310
Linear regression models were used to test observational associations between 311 the methylation and genetic scores for BMI against cardiovascular outcomes. 312
These were performed with and without adjustment for BMI and using other 313 covariates, as with other models. ANOVA tests were used to compare the relative 314 contributions of BMI and the genetic and methylation scores and results are 315 reported for these comparisons. 316
Results 317
Establishing associations between DNA methylation and BMI within time-points 318
The methylation score for BMI, derived from the Mendelson et al epigenome-319 wide association study (EWAS) [15] , was strongly associated with BMI in middle 320 aged mothers, explaining 10% of the variation in BMI (p=1.58E-23). The 321 association was weaker in mothers during pregnancy (2% variance explained, 322 p=2.31E-06) and in children at birth (2% variance explained, p=6.83E-05), 323 childhood (1% variance explained, p=2.23E-04) and adolescence (3% variance 324 explained, p=3.91E-11). Full results are presented in Table 2 . 325 were also associated with BMI, with the strongest association found for children 334 in adolescence with 5% variance explained in BMI (p=2.12E-10) and weaker 335 associations found at all other time points (see Table 2 for full results). 336
The genetic and methylation score associations appear to be mostly independent 337 (Table 3) , as the combined model with both genetic and methylation scores 338 performed better than both the methylation score (ANOVA test p-values ranged 339 from 1.93E-10 to 0.04) and genetic score models (ANOVA test p-values ranged 340 from 4.55E-21 to 1.28E-03) alone for all time points. This validates previous 341 findings that the genotype and DNA methylation explain independent subsets of 342 BMI variation [13, 15] . 343 
363
The BMI methylation score correlations exhibited similar patterns but were 364 generally lower than for BMI. Strongest correlations were observed in children 365 between age 7 and adolescence and in mothers between pregnancy and middle 366 age (R ~ 0.5). All other correlations were between 0.2 and 0.25. Thus, 367 methylation scores at birth were more highly correlated with later time points 368 and with maternal methylation scores than birthweight and BMI (Figure 2) . 369
Given the weak association of methylation in childhood with BMI, factors other 370 than BMI likely contribute to the correlation of DNA methylation over time and 371 between mothers and children. 372 
378
Finally, to examine whether there are particular CpG sites that correlate more 379 strongly over time and between paired children and mothers, we tested the 380 correlation of each site at different time points (Supplementary Table 1 , 381
Additional file 1). We observe that median correlations across all CpG sites 382 follow a similar pattern to correlations of the methylation scores over time, 383 where the strongest correlations were observed in children between age 7 and 384 adolescence and in mothers between pregnancy and middle age (R ~ 0.2). Only 385 these two sets of timepoints have CpG sites with correlation R > 0.5. There are 386 six such CpG sites for each and two of these are common to both (cg16611584, 387 cg24145109). Both of these CpG sites are highly correlated across all time 388
points. 389
Predicting future BMI with past DNA methylation scores 390
We next investigated whether the BMI methylation score was predictive of BMI 391 at later timepoints ( Table 4 ) or vice versa (if BMI was predictive of methylation 392 score at later timepoints; Table 5 ). We observed some evidence that methylation 393 score in childhood could be predictive of BMI in adolescence (p=0.004), although 394 the association disappeared when adjusting for childhood BMI (p=0.20) and 395 there was stronger evidence for the converse, that is BMI in childhood predicting 396 adolescent DNA methylation (p=1.52E-06 even when adjusting for childhood 397 methylation score). We observed the same in the mothers between pregnancy 398 and middle age; that is, the association between antenatal (earlier) methylation 399 score and middle-age (later) BMI (p=0.02) essentially disappears when adjusting 400 for antenatal (earlier) BMI (p=0.13). Also, the association between antenatal 401 (earlier) BMI and middle age (later) DNA methylation is much stronger even 402 when adjusting for antenatal (earlier) methylation score (p=5.48E-11). 403 
Exploration of temporal relationships between BMI and DNA methylation 415
To further evaluate the temporal associations between DNA methylation and 416 BMI, we used cross-lagged models to test which paths from earlier trait 417 measures and scores were important for later trait measures and scores. 418
Agreeing with the results from adjusted linear models, these did reveal a 419 pathway between BMI in childhood and methylation score in adolescence. 420 We used two-sample MR to explore causal relationships between DNA 445 methylation and BMI (Supplementary Table 2 , Additional file 1). Using the BMI 446 genetic score as an instrumental variable for BMI, we found little evidence for a 447 causal link of BMI on each of the 135 CpG sites used to construct the methylation 448 score (p-value range: 1.63E-03 -9.99E-01, for all timepoints, with a Bonferroni-449 adjusted p-value threshold of 3.7E-04). A combined p-value for all 135 CpG sites 450 obtained using Fisher's method similarly indicated no strong association 451 between the genetic score and methylation (p-value range: 0.82 -1.00, for all 452 timepoints). Furthermore, even when this analysis was repeated with a mixed 453 model including data from both adolescents and middle-aged mothers to 454 increase the power ( Supplementary Table 3 , Additional file 1), there was still 455 little evidence of association (p-value range: 2.13E-02 -9.98E-01). 456
The reverse causal direction, methylation variation causing BMI variation, was 457 investigated using mQTLs for the 135 methylation score CpG sites as 458 instrumental variables. These individual tests did not indicate a causal link 459 (Bonferroni-adjusted p-value threshold of 3.7E-04; Supplementary Table 4 , 460
Additional file 1) although combining the test p-values using Fisher's method did 461 provide weak evidence for a causal association (Fisher's p-value = 0.03). 462
Confounder analyses 463
Sensitivity analyses showed that associations between BMI and methylation 464 score remained unaffected by the inclusion of potential confounders in the 465 majority of models ( Supplementary Table 5 , Additional file 1). Smoking and 466 education appeared to be associated with methylation score in some models, 467 however, most of the associations between BMI and methylation score survived 468 these adjustments (p < 0.007 = 0.05/7). 469
Associations with cardiovascular traits 470 Finally, given that BMI is a risk factor for cardiovascular disease, we tested 471 within-timepoint associations between the DNA methylation and genetic scores 472 for BMI and cardiovascular traits to examine if the specificity of these scores. 473
Firstly, we observed that methylation associations were partially independent of 474 BMI for LDL (p=0.02) and glucose (p=0.03) in adolescence and triglycerides 475 (p=3.00E-03), LDL (p=0.01) and SBP (p=0.05) in mothers at middle age. 476
Similarly, we observed that methylation associations were partially independent 477 of genetic effects on SBP in adolescence (p=0.05) and triglycerides in mothers 478 (p=3.27E-03) ( Supplementary Table 6 , Additional file 1). We also observed that 479 genetic effects were partially independent of BMI for LDL (p=0.03), glucose 480 In this study we have demonstrated strong associations between DNA 493 methylation and genetic scores for BMI [15] in both adults and children. 494 Importantly, the use of temporal data indicates that the DNA methylation scores 495 are not predictive. While the association between DNA methylation scores and 496 BMI within time point are strong, the associations between earlier methylation 497 scores later BMI are weak, and these signals do not improve the model of simply 498 using earlier BMI as a predictor for later BMI. Hence, it may be more appropriate 499 to term the DNA methylation score as a biomarker rather than a cause or 500 predictor of BMI. 501
We observed within-timepoint associations between DNA methylation score for 502 BMI and health outcomes for which BMI is a risk factor. These associations were 503 independent of BMI and genotype, suggesting that the DNA methylation -BMI 504 associations might arise due to unmeasured confounders that also influence 505 those outcomes. DNA methylation could be used as a biomarker for these 506 outcomes, above and beyond BMI and genetic variation. 507
Our study builds upon previous research in this field showing that both genetic 508 and environmental factors contribute to variance in BMI [5, 23] . Previous work 509 investigating the relationship between DNA methylation and BMI has found 510 associations with specific DNA methylation sites [10-12]. However results from 511 these studies are fairly inconsistent and practical implications of these 512 associations have not yet been identified [27] . In extension of this previous 513 research we have used 135 CpG sites, identified in an EWAS meta-analysis [15], 514 to create methylation scores that are also associated with BMI in an independent 515 cohort. The main novel component of our study is that we look across the life 516 course in children and adults. Another study investigating DNA methylation 517 profile and obesity in children aged 6-14 years also found an association 518 between childhood obesity and a separate set of differentially methylated CpG 519 sites, supporting our finding that DNA methylation is associated with BMI in 520 adolescents [28] . Our findings in younger children were however weaker and 521 could be due to basing our analysis on methylation at CpG sites associated with 522 BMI in adults. 523
We have also investigated the nature of these associations further and found that 524 there may be some predictive capability of earlier BMI to later DNA methylation 525 at multiple time points, however we found no evidence to suggest this 526 association is causal, which could be due to several reasons. Firstly, it may be 527 that there is a lack of power in these analyses for MR to detect a causal 528 relationship. The Wahl et al paper [14] suggests that with larger sample sizes the 529 direction of effect is likely to be from BMI to DNA methylation. Therefore, it is 530 possible that with a larger sample size we could confirm this direction of 531 causality. It could also be that there are other unknown confounders, which are 532 mediating this effect and future research should focus on investigating this 533 further. Our MR analyses suggest a weak aggregate causal association from DNA 534 methylation to BMI, however due to the DNAm instruments being enriched for 535 genic regions, this association is unlikely to be stronger than expected against a 536 more appropriate null that reflects that BMI is more strongly influenced by 537 genetic variants in genic regions [23] . We also found associations of the BMI 538 DNAm scores with cardiovascular outcomes. If BMI causes changes in DNAm, as 539 our analyses seem to suggest, then DNAm changes may fall on the causal 540 pathway between BMI and these cardiovascular outcomes. Therefore, DNAm 541 scores may have potential use as predictors of cardiovascular outcomes, 542 although generalisability to other populations would need to be confirmed. This 543 has been suggested in previous studies for diabetes [14, 29] and insulin-544 resistance [30] . 545
Limitations 546
This study is subject to a number of limitations. Firstly, whilst the size of the 547 ARIES cohort is larger than or equivalent to samples used in other DNA 548 methylation studies, it may still be too small to detect some associations, and this 549 may be why we do not find any causal association for BMI to DNA methylation, 550 as discussed above. The ARIES mQTL database used in the two-sample MR had a 551 total sample size of 3,948, although this was split across three time points in 552 approximately the same children and two time points in the mothers. We used 553 the GIANT cohort for BMI in the two-sample MR and included 235,522 554 participants in these analyses. The GIANT sample size is much larger and 555 therefore it is difficult to directly compare the strength of causal evidence in each 556 direction between these samples. Secondly, whilst it is a strength of our study 557 that we use multiple time points, in the mothers one of these is during pregnancy 558 so these findings may not be generalizable outside of pregnancy, or generalizable 559 to males. As with any epidemiological study there may also be measurement 560 error present in our phenotypic data, for example smoking data was collected via 561 self-report and there may be biases present in this data because of this. In 562 addition, measurement error may be present in the genotyping data and 563 methylation data. Finally, the DNA methylation data was collected from blood 564 samples which may not be indicative of other tissue methylation levels such as 565 adipose tissue which may be more relevant in a study looking at potential causal 566 relationships between BMI and DNAm, however we assume the two may be 567 correlated to an extent. 568
Conclusions 569
In conclusion, our study finds that DNA methylation scores, as have so far been 570 generated, are unlikely to be predictive of future BMI using earlier DNA 571 methylation levels, and therefore is more appropriately considered a biomarker. 572
This indicates that conducting EWAS using DNAm values and trait values 573 measured at the same time point is not an effective strategy when attempting to 574 create predictors. Therefore, future studies should perform EWAS that test for 575 early DNAm values against later health outcomes to evaluate whether this may 576 enable creating an effective predictor, which could then be tested in other 577 populations. 578 579 580 581 582 University of Bristol provide core support for ALSPAC. This publication is the 623 work of the authors and ZER, MJS, CLR, OSPD and GH will serve as guarantors for 624 the contents of this paper. A comprehensive list of grants funding is available on 625 the ALSPAC website 626 
